Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ostelin-D is an oral combination supplement containing calcium carbonate and colecalciferol (vitamin D3). Developed and marketed by Everest Pharmaceuticals in Bangladesh, it is widely used for the prevention and treatment of calcium and vitamin D deficiencies, as well as an adjunct therapy in the management of bone disorders such as osteoporosis, osteomalacia, rickets, and tetany. Calcium carbonate provides elemental calcium, which is essential for bone mineralization, muscle contraction, and nerve transmission. Colecalciferol is a prohormone that undergoes hepatic and renal hydroxylation to its active form, calcitriol, which binds to the vitamin D receptor (VDR) to enhance intestinal calcium absorption and maintain calcium homeostasis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium carbonate + colecalciferol (Everest Pharmaceuticals).